1. Short title This Act may be cited as the Pandemic Supplies Production Act . 2. Findings Congress finds the following: (1) The global shortage of medical and sanitation supplies due to the COVID–19 pandemic has paralyzed health care systems and strained emergency response capabilities of governments around the world. (2) The pandemic demonstrated the interdependent nature and the limitations of global supply chains as both our nation and the world competes for a finite number of suppliers for critical medical and sanitation resources. (3) Providing a comprehensive understanding of how to procure, manage, deliver, and sustain at scale was necessary during this crisis, and will be critical as the U.S. replenishes current supplies and plans for future crises. (4) The Federal Emergency Management Agency and the Department of Health and Human Services were challenged to rapidly identify, procure, and deploy large quantities of goods and services while simultaneously responding and planning for the recovery of the United States from this global pandemic. (5) The traditional interagency emergency response structure, built to respond to natural disasters typically defined by geographic locales, does not have the capacity to scale quickly to address a crisis of this magnitude. (6) The Department of Defense leveraged acquisition and supply chain expertise are uniquely suited to rapidly scale and establish acquisition strategies, for both procurement of supplies, expansion of industrial capabilities and distribution of such supplies as the COVID–19 response requirements evolved. (7) As the combat logistics support agency for the Nation, the Defense Logistics Agency ( DLA ) manages the global supply chain—from raw materials to end user to disposition—for the Army, Marine Corps, Navy, Air Force, Space Force, Coast Guard, 11 combatant commands, other Federal agencies, and partner and allied nations. (8) DLA has supported the COVID–19 response of the Department of Defense by increasing the production and acquisition of